Search for: "All in Production, LLP" Results 281 - 300 of 4,212
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Feb 2022, 6:01 am by Bob Ambrogi
Losses to businesses from the theft of their trade secrets add up to as much as three percent of the U.S. gross domestic product, according to a 2014 report by the Center for Responsible Enterprise and Trade and PricewaterhouseCoopers LLP. [read post]
In the world of consumer products, the month of May was all about infant sleep products. [read post]
14 Mar 2021, 3:59 am by Administrator
Supreme Advocacy LLP offers a weekly electronic newsletter, Supreme Advocacy Letter, to which you may subscribe. [read post]
20 Nov 2006, 10:37 am
Gage was most recently vice president of marketing and product management for Destinator Technologies where he had global oversight for all aspects of marketing and product strategy. [read post]
20 Mar 2017, 1:01 pm by Bill Marler
“This calls into question the integrity of not only the products sold by SoyNut Butter Company, but all of those manufactured by Dixie Dew Products. [read post]
13 Apr 2022, 7:42 am by Dan Harris
Your China Manufacturing Risks RIGHT NOW Yesterday, product sourcing superstar Renaud Anjoran asked me on Linkedin to weigh in with my views on what is happening and what will happen with China manufacturing: In the next 12 months, will there be a wide area manufacturing consumer goods (say, all the North of Zhejiang, or all the Pearl River delta, or all of the South of Jiangsu) where the manufacture and/or the flow of materials gets stopped for several weeks? [read post]
15 Nov 2010, 11:48 am by Christina Sonsire
Thanks for reading and here’s to more productivity – and more down-time! [read post]
16 Aug 2023, 7:38 am by Dan Harris
Why do all of these terrible things happen to small businesses that want nothing more than to have good product made in China? [read post]
2 Feb 2023, 3:58 am by China Law Blog
Companies that have their products made in China are increasingly seeking to diversify their supply chains away from China and its COVID/Omicron factory shutdowns, rising energy costs and shortages, rising wages, high shipping costs, and “Trump tariffs” — all of which are likely to continue (at varying levels) indefinitely. [read post]
2 Feb 2023, 3:58 am by China Law Blog
The post Free Webinar, February 23: Moving your Manufacturing from China to Mexico appeared first on Harris Bricken Sliwoski LLP. [read post]
20 Feb 2023, 8:55 am by China Law Blog
Companies that have their products made in China are increasingly seeking to diversify their supply chains away from China and its COVID/Omicron factory shutdowns, rising energy costs and shortages, rising wages, high shipping costs, and “Trump tariffs” — all of which are likely to continue (at varying levels) indefinitely. [read post]
26 Mar 2007, 7:28 pm
Plaintiff seeks to recover damages on behalf of all members of the proposed Class. [read post]
18 Apr 2014, 5:43 am by Adam Weinstein
Couyoumjian has been the subject to disciplinary action by several states, FINRA, the Certified Financial Planner’s Board (“CFP”), and has had at least eight customer complaints filed against her all associated with allegations concerning high commission based investment products. [read post]
9 Jul 2020, 10:56 am by Seeger Weiss LLP
Notably, RenRX also consented to a 25-year exclusion from all federal healthcare programs. [read post]
9 Jul 2020, 10:56 am by Seeger Weiss LLP
Notably, RenRX also consented to a 25-year exclusion from all federal healthcare programs. [read post]
23 Apr 2019, 9:32 am by mockingbird4
This is because drug and medical device companies do not always disclose all of the potential risks of the products they sell. [read post]
27 Mar 2012, 7:00 am by Lucas A. Ferrara, Esq.
  CONTACT:    Newman Ferrara LLP Attorneys: Jeffrey M. [read post]
13 Mar 2024, 3:04 pm by Seeger Weiss
Seeger Weiss is pleased to announce that the firm was named one of The Legal 500 Top Product Liability, Mass Tort, and Class Action Firms. [read post]
24 Nov 2009, 9:07 am
In this release, the authors (Kaye Scholer LLP’s Patent Group) update and expand Pharmaceutical and Biotech Patent Law with new discussion of many topics, including double patenting, inequitable conduct, product by process claims, attorneys fees under Hatch-Waxman and more. [read post]